Nuñez Fernández, SilviaRivera, DiegoArroyo-Anlló, Eva MaríaOrtiz Jiménez, Xóchitl AngélicaCamino-Pontes, BorjaSalinas Martínez, RicardoArango Lasprilla, Juan Carlos2022-12-192022-12-192022Núñez-Fernández, S., Rivera, D., Arroyo-Anlló, E. M., Ortiz Jiménez, X. A., Camino-Pontes, B., Salinas Martínez, R., & Arango-Lasprilla, J. C. (2022). Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico. International Journal of Environmental Research and Public Health, 19(18), 11322. MDPI AG. Retrieved from http://dx.doi.org/10.3390/ijerph1918113221661-782710.3390/ijerph191811322https://academica-e.unavarra.es/handle/2454/44467To our knowledge, this is the first study reported in the literature that has validated the Norma Latina Battery in a population of people with Alzheimer’s disease (AD) in Mexico. The objective of the study was to determine the discriminant validity of the Norma Latina Battery in a group of Mexican individuals with AD and a group of heathy controls (HC). The Norma Latina Battery was administered to 234 Mexican participants (117 HC and 117 individuals with AD). Results show that: (1) the Norma Latina Battery has high discriminative capacity between groups in all domains; (2) participants with AD presented worse scores in each of the cognitive domains compared to the HC and a greater number of low scores in each of the established thresholds or cut-off points; and finally, (3) the Norma Latina Battery had optimal sensitivity and specificity, especially when a set was observed ≥5 scores below the 10th percentile or ≥4 scores below the 5th percentile. In conclusion, it is recommended that both clinicians and researchers use this battery in the evaluation of Mexican people with AD to better understand the prognosis of the disease and its subsequent treatment.application/pdfapplication/zipeng© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) licenseAlzheimer's diseaseCognitive problemsLatin AmericaMexicoNeuropsychological assessmentArtículo / Artikulua2022-12-19Acceso abierto / Sarbide irekiainfo:eu-repo/semantics/openAccess